NMR PROTON CHEMICAL SHIFT IMAGING
核磁共振质子化学位移成像
基本信息
- 批准号:2090182
- 负责人:
- 金额:$ 31.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-07-01 至 1998-04-30
- 项目状态:已结题
- 来源:
- 关键词:Huntington's disease Parkinson's disease bioenergetics brain disorder diagnosis cerebral ischemia /hypoxia computer simulation diagnosis quality /standard disease /disorder model electron transport human subject laboratory rabbit laboratory rat lactates magnetic resonance imaging neural degeneration nuclear magnetic resonance spectroscopy oxygen transport phantom model positron emission tomography technology /technique
项目摘要
The goal of this research is to refine the capacity of proton NMR
to acquire images displaying chemical shift spectral information,
and to assess the role of these methods in vivo in clinical and
basic research. As in our initial submission, two areas of
investigation will be studied in detail.
First, quantitative techniques of lipid and water imaging,
evaluated during the initial funding period, will be further
extended to measure additional spectral characteristics. These
will include spectral resonance line broadening measured using an
asymmetric spin echo (ASE) method, and scalar coupled fraction
(SCF) measured using multiple quantum techniques. Two applications
are planned. Following on the success of pilots studies funded
during the initial study period, the clinical utility of
quantitative analysis of lipid and water resonance concentration,
relaxation times, and newly developed measures of spectral line
widths will be evaluated in disorders of bone marrow. This will
include detailed longitudinal studies of myeloproliferative
disorders, and pilot studies of chemical shift imaging (CSI)
techniques to measure marrow iron stores. Research will also begin
on quantitative spectral imaging of atherosclerotic plaque. Work
will focus on characterization of fatty plaques with lipid-
sensitive and multiple quantum pulse sequences, and atherosclerotic
arterial thrombus with iron-sensitive line width mapping. These
studies will be directed towards establishing quantitative CSI as
a non-invasive tool for evaluating the response of arterial lesions
to new interventions such as laser angioplasty.
Second, mapping lactate in cerebral ischemia will form the
cornerstone of studies of brain physiology. Technical issues to
be addressed will include improved methods of lipid suppression
(previous work having demonstrated solutions to the problem of in
vivo water suppression), and comparison between field strengths.
Physiologic correlates to lactate maps including MR and PET
measures of cerebral blood flow, brain pH and oxygen metabolism,
will be used in both global hypoxia and focal ischemia to address
questions of brain energy metabolism and pH regulation.
本研究的目标是改进质子核磁共振的能力
为了获取显示化学位移光谱信息的图像,
并评估这些方法在临床和体内的作用,
基础研究 与我们最初提交的报告一样,
调查将进行详细研究。
首先,脂质和水成像的定量技术,
在最初的融资期间,将进一步评估
扩展到测量额外的光谱特性。 这些
将包括光谱共振线展宽测量使用
非对称自旋回波(ASE)方法和标量耦合分数
(SCF)使用多重量子技术测量。 两个应用程序
都计划好了 在资助的试点研究取得成功之后,
在最初的研究期间,
脂质和水共振浓度的定量分析,
弛豫时间和新开发的谱线测量
将在骨髓疾病中评估宽度。 这将
包括骨髓增生的详细纵向研究,
化学位移成像(CSI)的初步研究
测量骨髓铁储备的技术。 研究也将开始
动脉粥样硬化斑块的定量光谱成像。 工作
将重点关注脂肪斑块的特征与脂质-
敏感和多量子脉冲序列,以及动脉粥样硬化
动脉血栓与铁敏感线宽映射。 这些
研究将致力于建立量化的CSI,
用于评估动脉病变反应的非侵入性工具
激光血管成形术等新的介入治疗。
其次,绘制脑缺血中的乳酸盐将形成
大脑生理学研究的基石 技术问题
将包括改进的脂质抑制方法
(以前的工作已经证明了解决问题的办法,
体内水抑制)和场强之间的比较。
生理学与乳酸图相关,包括MR和PET
测量脑血流量、脑pH值和氧代谢,
将用于全身缺氧和局灶性缺血,
大脑能量代谢和pH调节的问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRUCE R ROSEN其他文献
BRUCE R ROSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRUCE R ROSEN', 18)}}的其他基金
Upgrade the 14T Ultrahigh Field Horizontal MR Scanner for Rodent and ex-vivo Imaging
升级 14T 超高场水平 MR 扫描仪,用于啮齿动物和离体成像
- 批准号:
10175835 - 财政年份:2021
- 资助金额:
$ 31.29万 - 项目类别:
相似海外基金
Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
- 批准号:
2907463 - 财政年份:2024
- 资助金额:
$ 31.29万 - 项目类别:
Studentship
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 31.29万 - 项目类别:
Research Grant
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
- 批准号:
2898794 - 财政年份:2024
- 资助金额:
$ 31.29万 - 项目类别:
Studentship
The Diagnostic and Prognostic Utility of Eye Tracking in Parkinson's Disease and Related Disorders
眼动追踪在帕金森病及相关疾病中的诊断和预后效用
- 批准号:
479285 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别:
Operating Grants
Neurophysiological mechanism underlying freezing of gait in Parkinson's disease: transcutaneous spinal cord stimulation for gait disturbance
帕金森病步态冻结的神经生理机制:经皮脊髓刺激治疗步态障碍
- 批准号:
23K10409 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inhibition of cell-to-cell propagation of alpha-synuclein aggregation by glial cells and its involvement in neuropathology in Parkinson's disease.
神经胶质细胞抑制α-突触核蛋白聚集的细胞间传播及其参与帕金森病的神经病理学。
- 批准号:
23K06928 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Propagation of a-synuclein in Parkinson's disease progress
α-突触核蛋白在帕金森病进展中的传播
- 批准号:
22KJ2095 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Drug-microbiome-host interactions in Parkinson's disease
帕金森病的药物-微生物组-宿主相互作用
- 批准号:
2881438 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别:
Studentship
Ordering the disordered in Parkinson's disease to derive peptide inhibitors of alpha-synuclein toxicity
命令帕金森病患者衍生出α-突触核蛋白毒性的肽抑制剂
- 批准号:
2884235 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别:
Studentship
MICA: How does the pedunculopone nucleus influence treatment responses in Parkinson's disease, and can it be targeted for new treatment strategies
MICA:脚核如何影响帕金森病的治疗反应,是否可以作为新治疗策略的目标
- 批准号:
MR/X005267/1 - 财政年份:2023
- 资助金额:
$ 31.29万 - 项目类别:
Research Grant














{{item.name}}会员




